Abstract
Introduction: We aimed to identify factors affecting percutaneous nephrolithotomy (PNL) outcomes among patients with horseshoe kidney (HSK) and assess the predictive accuracy of the Clinical Research Office of the Endourological Society (CROES), Guy’s Stone Score (GSS), and S.T.O.N.E. scoring systems. Methods: Data from 98 patients with HSK who underwent PNL between November 2010 and January 2020 were evaluated. Patients were divided into the stone-free (SF) and non-SF groups and compared according to demographic data, stone and surgical characteristics, and stone scoring systems. Multivariate logistic regression analysis was performed to identify factors associated with SF status. Results: Among the included patients, 87 were male and 11 were female (mean age: 47.37 ± 14.42 years). The SF rate was 84.7% (83 patients). Group analysis identified GSS (p < 0.001), CROES score (p < 0.001), S.T.O.N.E. score (p = 0.014), stone burden (p = 0.045), and multiplicity (p < 0.001) as factors associated with SF status. Among our cohort, 10 patients developed complications. All scoring systems were significantly correlated with SF status (CROES: r = −0.442, p < 0.001; GSS: r = 0.442, p < 0.001; S.T.O.N.E.: r = 0.250, p = 0.013), while CROES score was identified as an independent factor associated with SF status (95% CI: 0.937–0.987; p = 0.003). Conclusions: PNL is an effective method for treating nephrolithiasis among patients with HSK. Moreover, stone-related factors, such as larger size, multiplicity, and complexity, were associated with procedural failure. Finally, the CROES nomogram was a better predictor of SF status compared with other scoring systems.
References
1.
Weizer
AZ
, Silverstein
AD
, Auge
BK
, Delvecchio
FC
, Raj
G
, Albala
DM
, et al. Determining the incidence of horseshoe kidney from radiographic data at a single institution
. J Urol
. 2003
;170
(5
):1722
–6
. 2.
Yohannes
P
, Smith
AD
. The endourological management of complications associated with horseshoe kidney
. J Urol
. 2002
;168
(1
):5
–8
. 3.
Raj
GV
, Auge
BK
, Assimos
D
, Preminger
GM
. Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys
. J Endourol
. 2004
;18
(2
):157
–61
. 4.
Chen
H
, Chen
G
, Pan
Y
, Zhu
Y
, Xiong
C
, Chen
H
, et al. No wound for stones
. Urol Int
. 2019
;103
(3
):249
–55
. 5.
Sheir
KZ
, Madbouly
K
, Elsobky
E
, Abdelkhalek
M
. Extracorporeal shock wave lithotripsy in anomalous kidneys: 11-year experience with two second-generation lithotripters
. Urology
. 2003
;62
(1
):10
–5
. 6.
Viola
D
, Anagnostou
T
, Thompson
TJ
, Smith
G
, Moussa
SA
, Tolley
DA
. Sixteen years of experience with stone management in horseshoe kidneys
. Urol Int
. 2007
;78
(3
):214
–8
. 7.
Stein
RJ
, Desai
MM
. Management of urolithiasis in the congenitally abnormal kidney (horseshoe and ectopic)
. Curr Opin Urol
. 2007
;17
(2
):125
–31
. 8.
Molimard
B
, Al-Qahtani
S
, Lakmichi
A
, Sejiny
M
, Gil-Diez de Medina
S
, Carpentier
X
, et al. Flexible ureterorenoscopy with holmium laser in horseshoe kidneys
. Urology
. 2010
;76
(6
):1334
–7
. 9.
Atis
G
, Resorlu
B
, Gurbuz
C
, Arikan
O
, Ozyuvali
E
, Unsal
A
, et al. Retrograde intrarenal surgery in patients with horseshoe kidneys
. Urolithiasis
. 2013
;41
(1
):79
–83
. 10.
Turk
C
, Skolarikos
A
, Neisius
A
, Petrik
A
, Seitz
C
, Thomas
K
. Guidelines on Urolithiasis
. Available from
: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urolithiasis-2019.pdf11.
Shokeir
AA
, El-Nahas
AR
, Shoma
AM
, Eraky
I
, El-Kenawy
M
, Mokhtar
A
, et al. Percutaneous nephrolithotomy in treatment of large stones within horseshoe kidneys
. Urology
. 2004
;64
(3
):426
–9
. 12.
Miller
NL
, Matlaga
BR
, Handa
SE
, Munch
LC
, Lingeman
JE
. The presence of horseshoe kidney does not affect the outcome of percutaneous nephrolithotomy
. J Endourol
. 2008
;22
(6
):1219
–25
. 13.
Gupta
NP
, Mishra
S
, Seth
A
, Anand
A
. Percutaneous nephrolithotomy in abnormal kidneys: single-center experience
. Urology
. 2009
;73
(4
):710
–4
. 14.
Ozden
E
, Bilen
CY
, Mercimek
MN
, Tan
B
, Sarikaya
S
, Sahin
A
. Horseshoe kidney: does it really have any negative impact on surgical outcomes of percutaneous nephrolithotomy?
Urology
. 2010
;75
(5
):1049
–52
. 15.
Skolarikos
A
, Binbay
M
, Bisas
A
, Sari
E
, Bourdoumis
A
, Tefekli
A
, et al. Percutaneous nephrolithotomy in horseshoe kidneys: factors affecting stone-free rate
. J Urol
. 2011
;186
(5
):1894
–8
. 16.
Tepeler
A
, Sehgal
PD
, Akman
T
, Unsal
A
, Ozyuvali
E
, Armagan
A
, et al. Factors affecting outcomes of percutaneous nephrolithotomy in horseshoe kidneys
. Urology
. 2014
;84
(6
):1290
–4
. 17.
Etemadian
M
, Maghsoudi
R
, Abdollahpour
V
, Amjadi
M
. Percutaneous nephrolithotomy in horseshoe kidney: our 5-year experience
. Urol J
. 2013
;10
(2
):856
–60
.18.
Tefekli
A
, Ali Karadag
M
, Tepeler
K
, Sari
E
, Berberoglu
Y
, Baykal
M
, et al. Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard
. Eur Urol
. 2008
;53
(1
):184
–90
. 19.
de la Rosette
JJ
, Zuazu
JR
, Tsakiris
P
, Elsakka
AM
, Zudaire
JJ
, Laguna
MP
, et al. Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the Clavien classification
. J Urol
. 2008
;180
(6
):2489
–93
. 20.
Turna
B
, Umul
M
, Demiryoguran
S
, Altay
B
, Nazli
O
. How do increasing stone surface area and stone configuration affect overall outcome of percutaneous nephrolithotomy?
J Endourol
. 2007
;21
(1
):34
–43
. 21.
Thomas
K
, Smith
NC
, Hegarty
N
, Glass
JM
. The Guy’s stone score: grading the complexity of percutaneous nephrolithotomy procedures
. Urology
. 2011
;78
(2
):277
–81
. 22.
Smith
A
, Averch
TD
, Shahrour
K
, Opondo
D
, Daels
FP
, Labate
G
, et al. A nephrolithometric nomogram to predict treatment success of percutaneous nephrolithotomy
. J Urol
. 2013
;190
(1
):149
–56
. 23.
Okhunov
Z
, Friedlander
JI
, George
AK
, Duty
BD
, Moreira
DM
, Srinivasan
AK
, et al. S.T.O.N.E. nephrolithometry: novel surgical classification system for kidney calculi
. Urology
. 2013
;81
(6
):1154
–9
. 24.
Michel
MS
, Trojan
L
, Rassweiler
JJ
. Complications in percutaneous nephrolithotomy
. Eur Urol
. 2007
;51
(4
):899
–906
. 25.
Labadie
K
, Okhunov
Z
, Akhavein
A
, Moreira
DM
, Moreno-Palacios
J
, del Junco
M
, et al. Evaluation and comparison of urolithiasis scoring systems used in percutaneous kidney stone surgery
. J Urol
. 2015
;193
(1
):154
–9
. 26.
Tailly
TO
, Okhunov
Z
, Nadeau
BR
, Huynh
MJ
, Labadie
K
, Akhavein
A
, et al. Multicenter external validation and comparison of stone scoring systems in predicting outcomes after percutaneous nephrolithotomy
. J Endourol
. 2016
;30
(5
):594
–601
. 27.
Aldaqadossi
HA
, Khairy Salem
H
, Kotb
Y
, Hussein
HA
, Shaker
H
, Dikaios
N
. Prediction of pediatric percutaneous nephrolithotomy outcomes using contemporary scoring systems
. J Urol
. 2017
;198
(5
):1146
–52
. 28.
Ozgor
F
, Yanaral
F
, Savun
M
, Ozdemir
H
, Sarilar
O
, Binbay
M
. Comparison of STONE, CROES and Guy’s nephrolithometry scoring systems for predicting stone-free status and complication rates after percutaneous nephrolithotomy in obese patients
. Urolithiasis
. 2018
;46
(5
):471
–7
. 29.
Sfoungaristos
S
, Gofrit
ON
, Pode
D
, Landau
EH
, Duvdevani
M
. Percutaneous nephrolithotomy for staghorn stones: which nomogram can better predict postoperative outcomes?
World J Urol
. 2016
;34
(8
):1163
–8
. 30.
Yanaral
F
, Ozgor
F
, Savun
M
, Sahan
M
, Sarilar
O
, Binbay
M
. Comparison of CROES, S.T.O.N.E, and Guy’s scoring systems for the prediction of stone-free status and complication rates following percutaneous nephrolithotomy in patients with chronic kidney disease
. Int Urol Nephrol
. 2017
;49
(9
):1569
–75
. 31.
Kocaaslan
R
, Tepeler
A
, Buldu
I
, Tosun
M
, Utangac
MM
, Karakan
T
, et al. Do the urolithiasis scoring systems predict the success of percutaneous nephrolithotomy in cases with anatomical abnormalities?
Urolithiasis
. 2017
;45
(3
):305
–10
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
